Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Clinical trial NCT06630611 · RECRUITING

Trial details

NCT number: NCT06630611
Sponsor: Vall d'Hebron Institute of Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Non Small Cell Lung Cancer Cervical Cancer

Start date: 2025-01-15
Primary completion: 2029-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.